These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 1602891)
21. [Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases]. Tomihira M Fukuoka Igaku Zasshi; 1991 Jan; 82(1):21-30. PubMed ID: 1708742 [TBL] [Abstract][Full Text] [Related]
22. Persistent elevation of the aminoterminal peptide of procollagen type III in serum of patients with acute viral hepatitis distinguishes chronic active hepatitis from resolving or chronic persistent hepatitis. Annoni G; Cargnel A; Colombo M; Hahn EG J Hepatol; 1986; 2(3):379-88. PubMed ID: 3722792 [TBL] [Abstract][Full Text] [Related]
23. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis. Teare JP; Sherman D; Greenfield SM; Simpson J; Bray G; Catterall AP; Murray-Lyon IM; Peters TJ; Williams R; Thompson RP Lancet; 1993 Oct; 342(8876):895-8. PubMed ID: 8105167 [TBL] [Abstract][Full Text] [Related]
24. Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease. Hayasaka A; Schuppan D; Ohnishi K; Okuda K; Hahn EG J Hepatol; 1990 Jan; 10(1):17-22. PubMed ID: 2307825 [TBL] [Abstract][Full Text] [Related]
25. [Serum fibrosis markers in diagnosing liver fibrosis]. Liu J; Wang JY; Lu Y Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):475-7. PubMed ID: 16831325 [TBL] [Abstract][Full Text] [Related]
26. The serum concentrations of the aminoterminal propeptide of procollagen type III and the hepatic content of mRNA for the alpha 1 chain of procollagen type III in carbon tetrachloride-induced rat liver fibrogenesis. Hayasaka A; Koch J; Schuppan D; Maddrey WC; Hahn EG J Hepatol; 1991 Nov; 13(3):328-38. PubMed ID: 1725528 [TBL] [Abstract][Full Text] [Related]
27. High serum levels of procollagen type III N-terminal amino peptide in patients with congenital heart disease. Sugimoto M; Masutani S; Seki M; Kajino H; Fujieda K; Senzaki H Heart; 2009 Dec; 95(24):2023-8. PubMed ID: 19666460 [TBL] [Abstract][Full Text] [Related]
28. Clinical significance of serum type-III procollagen aminopropeptide in hepatitis B virus-related liver diseases. Chang TT; Lin HC; Lee SD; Tsai YT; Lee FY; Jeng FS; Wu JC; Yeh PS; Lo KJ Scand J Gastroenterol; 1989 Jun; 24(5):533-8. PubMed ID: 2762752 [TBL] [Abstract][Full Text] [Related]
29. Serum concentration of the aminoterminal procollagen type III peptide in the rat reflects early formation of connective tissue in experimental liver cirrhosis. Schuppan D; Dumont JM; Kim KY; Hennings G; Hahn EG J Hepatol; 1986; 3(1):27-37. PubMed ID: 3745883 [TBL] [Abstract][Full Text] [Related]
31. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. Guéchot J; Poupon RE; Giral P; Balkau B; Giboudeau J; Poupon R J Hepatol; 1994 Mar; 20(3):388-93. PubMed ID: 8014451 [TBL] [Abstract][Full Text] [Related]
32. Role of the measurement of serum procollagen type III N-terminal peptide in the evaluation of liver diseases. Collazos J; Díaz F Clin Chim Acta; 1994 Jun; 227(1-2):37-43. PubMed ID: 7955420 [TBL] [Abstract][Full Text] [Related]
33. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636 [TBL] [Abstract][Full Text] [Related]
34. Serum amino-terminal propeptide of type III procollagen levels in chronic pancreatitis. Navarro S; Valderrama R; Lopez JM; Gimenez A; Caballeria J; Pares A; Fernandez-Cruz L Pancreas; 1996 Mar; 12(2):153-8. PubMed ID: 8720662 [TBL] [Abstract][Full Text] [Related]
35. [Measurement of serum type III procollagen aminopeptide with RIA-gnost PIIIP coated tube: changes in patients with various alcoholic liver diseases after abstinence]. Maruyama K; Okazaki I; Takagi T; Takahashi H; Okuyama K; Horie Y; Takagi S; Kohno H; Sato S; Ishii H Kaku Igaku; 1992 Feb; 29(2):151-7. PubMed ID: 1564787 [TBL] [Abstract][Full Text] [Related]
36. Alpha-interferon improves liver fibrosis in chronic hepatitis C: clinical significance of the serum N-terminal propeptide of procollagen type III. Serejo F; Costa A; Oliveira AG; Ramalho F; Batista A; De Moura MC Dig Dis Sci; 2001 Aug; 46(8):1684-9. PubMed ID: 11508668 [TBL] [Abstract][Full Text] [Related]
37. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease. Ergelen R; Akyuz U; Aydin Y; Eren F; Yilmaz Y Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):667-71. PubMed ID: 25923941 [TBL] [Abstract][Full Text] [Related]
38. Predictive role of serum procollagen III peptide and Knodell's index in survival prognosis of patients with hepatitis B virus liver cirrhosis. Babić Z; Bilić A; Babić D; Jagić V; Nikolić B; Sunić M Wien Klin Wochenschr; 2003 May; 115(9):302-8. PubMed ID: 12793031 [TBL] [Abstract][Full Text] [Related]
39. [Hepatic fibrosis and its serum markers]. Okabe K Rinsho Byori; 1992 Dec; 40(12):1258-64. PubMed ID: 1339165 [TBL] [Abstract][Full Text] [Related]
40. Diagnostic and prognostic value of the determination of the aminopropeptide of type III procollagen in patients with primary liver cancer. Farinati F; Annoni G; Donato MF; Nardelli P; Bertozzo A; De Maria N; Zotti S; Salvagnini M; Martinez D; Naccarato R J Gastroenterol Hepatol; 1990; 5(6):633-8. PubMed ID: 1966598 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]